Data di Pubblicazione:
2021
Abstract:
Excessive daytime sleepiness (EDS) affects a large percentage of Parkinson's disease (PD) patients, and it is enhanced by dopamine agonist drugs. Currently, there is no treatment of choice for EDS in PD. Our aim was to check the clinical impression that some patients who were given selegiline, a selective inhibitor of monoamine oxidase B, experienced an improvement in their daytime somnolence.
Tipologia CRIS:
Articolo su Rivista
Keywords:
Parkinson’s disease; Selegiline; sleepiness
Elenco autori:
Gallazzi, Marco; Mauri, Marco; Bianchi, Maria Laura; Riboldazzi, Giulio; Princiotta Cariddi, Lucia; Carimati, Federico; Rebecchi, Valentina; Versino, Maurizio
Link alla scheda completa:
Pubblicato in: